title: Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy.
abstract: Both the addition of neoadjuvant chemoradiation therapy and improvements in surgical techniques have improved local control and overall survival for locally advanced rectal cancer patients over the past few decades. The addition of adjuvant chemotherapy has likely improved outcomes as well, though the contribution has been more difficult to quantify. At present, the majority of resected locally advanced rectal cancer patients receive adjuvant chemotherapy, though there is great variability in this practice based on both patient and institution characteristics. Recently, questions have been raised regarding which sub-groups of patients benefit most from adjuvant chemotherapy. As pathologic complete response (pCR) is increasingly found to be a reasonable surrogate for long-term favorable outcomes, some have questioned the need for adjuvant therapy in this select group of patients. Multiple retrospective analyses have shown minimal to no benefit for adjuvant chemotherapy in this group. Indeed, the patients most consistently shown to benefit from adjuvant therapy both in terms of disease free survival (DFS) and overall survival (OS) are those who achieve an intermediate pathologic response to neoadjuvant treatment. Tumors that have high expression of thymidylate synthetase have also shown to benefit from adjuvant therapy. More study is needed into clinical and molecular features that predict patient benefit from adjuvant therapy.
authors: Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60601, USA.
authors: Valerie M
authors: VM
authors: Nelson
authors: Al B
authors: AB
authors: Benson
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism; D017024:Chemotherapy, Adjuvant / Q000379:methods; D002986:Clinical Trials as Topic; D006801:Humans; D020360:Neoadjuvant Therapy; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013940:Thymidylate Synthase / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D013940:Thymidylate Synthase
references: Br J Surg. 2003 Aug;90(8):996-8
references: 12905554
references: Am J Clin Oncol. 2001 Apr;24(2):107-12
references: 11319280
references: Biochemistry. 1974 Jan 29;13(3):471-81
references: 4203910
references: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references: 22237781
references: Lancet. 2009 Mar 7;373(9666):821-8
references: 19269520
references: Dis Colon Rectum. 2006 Sep;49(9):1284-92
references: 16758130
references: J Gastrointest Surg. 2005 Jan;9(1):90-9; discussion 99-101
references: 15623449
references: Biochim Biophys Acta. 1977 Dec 23;473(2):73-92
references: 145246
references: Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):528-35
references: 14751524
references: J Clin Oncol. 2010 Apr 1;28(10):1638-44
references: 20194850
references: Cancer Res. 1982 Feb;42(2):450-6
references: 6173112
references: J Clin Oncol. 2007 Oct 1;25(28):4379-86
references: 17906203
references: J Natl Cancer Inst. 1988 Mar 2;80(1):21-9
references: 3276900
references: J Clin Oncol. 1994 Dec;12(12):2640-7
references: 7989939
references: J Clin Oncol. 2013 Jan 1;31(1):30-8
references: 23169502
references: N Engl J Med. 2004 Oct 21;351(17):1731-40
references: 15496622
references: Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):99-107
references: 18407433
references: Lancet Oncol. 2012 Jun;13(6):579-88
references: 22503032
references: J Clin Oncol. 2012 May 20;30(15):1770-6
references: 22493423
references: Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):664-74
references: 12062610
references: Ann Surg Oncol. 2010 Nov;17(11):2863-9
references: 20552409
references: Dis Colon Rectum. 2011 May;54(5):518-25
references: 21471751
references: Ann Surg. 2011 Apr;253(4):711-9
references: 21475011
references: Ann Surg Oncol. 2012 Feb;19(2):392-401
references: 21792506
references: Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):871-6
references: 21377810
references: J Clin Oncol. 2003 Apr 1;21(7):1293-300
references: 12663717
references: J Nucl Med. 2009 May;50 Suppl 1:43S-54S
references: 19403879
references: J Natl Compr Canc Netw. 2009 Sep;7(8):895-904
references: 19755049
references: J Clin Oncol. 2007 Oct 1;25(28):4339-40
references: 17906196
references: Colorectal Dis. 2006 Sep;8 Suppl 3:21-4
references: 16813588
references: Am J Clin Oncol. 2006 Jun;29(3):219-24
references: 16755173
references: Ann Oncol. 2011 Mar;22(3):650-656
references: 20847032
references: Cancer Treat Rep. 1987 Mar;71(3):261-5
references: 3815393
references: Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8
references: 15383798
references: Lancet Oncol. 2012 Jul;13(7):679-87
references: 22627104
references: Ann Surg Oncol. 2011 Nov;18(12):3278-84
references: 21590453
references: Cancer. 2013 Apr 15;119(8):1521-7
references: 23288663
references: N Engl J Med. 2006 Sep 14;355(11):1114-23
references: 16971718
references: Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):843-56
references: 11020583
references: Colorectal Dis. 2009 Mar;11(3):249-53
references: 18513192
references: J Clin Oncol. 2009 Jul 1;27(19):3109-16
references: 19451431
references: J Clin Oncol. 2011 Dec 10;29(35):4633-40
references: 22067400
references: Lancet Oncol. 2007 Jul;8(7):625-33
references: 17613424
references: Am J Gastroenterol. 2006 Jun;101(6):1320-8
references: 16771956
references: Mol Pharmacol. 1993 Apr;43(4):527-33
references: 8474431
references: Radiology. 2004 Sep;232(3):773-83
references: 15273331
references: Int J Cancer. 2012 Dec 1;131(11):2604-11
references: 22447461
references: J Clin Oncol. 2006 Oct 1;24(28):4620-5
references: 17008704
references: Surg Oncol. 2011 Dec;20(4):e149-55
references: 21632237
references: Cancer. 2007 May 1;109(9):1750-5
references: 17387743
references: J Clin Oncol. 2011 Jul 10;29(20):2773-80
references: 21606427
references: J Clin Oncol. 2006 Sep 1;24(25):4062-8
references: 16943523
references: J Clin Oncol. 2005 Mar 20;23(9):1826-38
references: 15774776
references: J Clin Oncol. 1999 Aug;17(8):2396
references: 10561302